SCM
PYXS icon

Superstring Capital Management’s Pyxis Oncology PYXS Stock Holding History

Superstring Capital Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-484,443
Closed -$1.6M – 43
2024
Q2 		$1.6M Sell
484,443
-9,316
-2% -$39.2K 2.02% 15
2024
Q1 		$2.1M Buy
+493,759
New +$2.08M 1.39% 22

Other funds holding PYXS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Superstring Capital Management's PYXS Position: Q3 2024 in Review

Superstring Capital Management sold out of Pyxis Oncology (PYXS) in Q3 2024, closing a stake of 484,443 shares — an estimated $1.6M sold.

Superstring Capital Management first reported a position in PYXS in Q1 2024 and held it in 2 quarters. The position peaked at $2.1M in Q1 2024. 92 funds tracked by Wall St. Rank hold PYXS as of Q3 2024.

  • Superstring Capital Management reported no remaining Pyxis Oncology position as of Q3 2024 after selling out during the quarter.
  • Superstring Capital Management sold 484,443 Pyxis Oncology shares in Q3 2024, an estimated $1.6M.
  • Superstring Capital Management first reported a position in Pyxis Oncology in Q1 2024 and held it in 2 quarters.
  • Superstring Capital Management's Pyxis Oncology position peaked at $2.1M in Q1 2024.
  • 92 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2024.

Based on Superstring Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.